Filtered By:
Management: Government
This page shows you your search results in order of relevance. This is page number 4.
Order by Relevance | Date
Total 334 results found since Jan 2013.
Gov’t: Food Allergies May Be Disability Under Law
WASHINGTON (AP) — Allergic to gluten? What about peanuts? Federal disabilities law may be able to help.
The Justice Department said in a recent settlement with a Massachusetts college that severe food allergies can be considered a disability under the law. That gives those who suffer from such allergies a new avenue in seeking menus that fit their diet. But some say it goes too far.
The decision leaves schools, restaurants and other places that serve food more exposed to legal challenges if they fail to honor requests for accommodations by people with food allergies.
Colleges and universities are especially vulnerable be...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - January 18, 2013 Category: Consumer Health News Authors: deanreddington Tags: Health Local News Cambridge Food Allergies gluten-free foods Lesley University Source Type: news
Liberia-US clinical research partnership opens trial to test Ebola treatments
(NIH/National Institute of Allergy and Infectious Diseases) In partnership with the Liberian government, the National Institute of Allergy and Infectious Diseases today launched a clinical trial to obtain safety and efficacy data on the investigational drug ZMapp as a treatment for Ebola virus disease. The study, which will be conducted in Liberia and the United States, is a randomized controlled trial enrolling adults and children with known Ebola virus infection.
Source: EurekAlert! - Medicine and Health - February 27, 2015 Category: Global & Universal Source Type: news
More than Cosmetic Changes: Taking Stock of Personal Care Product Safety
Joe Greco, principal scientist in beauty care product development for Johnson & Johnson, works on reformulating an acne gel cleanser. Johnson & Johnson is one of several companies investing considerable resources to remove specific chemicals from their products.© Rebecca Kessler
An infographic prepared by the PCPC lays out the order of events and estimated timeframe for reformulating products.© Personal Care Products Council
In 2013 Johnson & Johnson completed reformulation of about 100 baby products, a process that involved approximately 1,500 prototypes. Some prototyp...
Source: EHP Research - May 1, 2015 Category: Environmental Health Authors: Web Admin Tags: Featured Focus News Allergies and Policy Chemical Sensitivities Chemical Testing Children's Health Endocrine Disruptors Health Disparities Industry Issues Laws May 2015 Organic Farming and Products Personal Care Products Regu Source Type: research
Soaring EpiPen Prices Raise Questions About Pharmaceutical Industry
BOSTON (CBS) – For someone with an allergy, an EpiPen can mean the difference between life and death. The price of this indispensable injectable drug has soared in recent years. Dr. Mark DeMatteo, an emergency room doctor at Beth Israel Deaconess in Plymouth, said the cost was around $60 ten years ago. The price now is about $400.
Every bite Dylan Frazier takes needs to be watched closely because the 9-year-old from Duxbury has severe food allergies.
“If we don’t have an EpiPen and he has a reaction, it could be deathly for him,” explained his mother Kristen Frazier.
Frazier makes sure there are EpiPens near Dy...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - October 22, 2015 Category: Consumer Health News Authors: rachelrmcknight Tags: Health Local News Seen On WBZ-TV Syndicated Local Allergies Dr. Mallika Marshall Source Type: news
Racial and Ethnic Disparities in Research Studies: The Challenge of Creating More Diverse Cohorts
This reporting project was funded through a grant provided by the Reporting Award at New York University’s Arthur L. Carter Journalism Institute.
Background image: Bahri Altay/Shutterstock
About This Article open
Citation: Konkel L. 2015. Racial and ethnic disparities in research studies: the challenge of creating more diverse cohorts. Environ Health Perspect 123:A297–A302; http://dx.doi.org/10.1289/ehp.123-A297
Published: 1 December 2015
PDF Version (873 KB)
Minority populations are much less likely than their white counterparts to be included in studies on environmentally related diseases, even t...
Source: EHP Research - December 1, 2015 Category: Environmental Health Authors: Web Admin Tags: Featured News Spheres of Influence December 2015 Source Type: research
Mylan CEO Testifies on EpiPen Cost
WASHINGTON (AP) — Mylan CEO Heather Bresch infuriated lawmakers as she tried — and mostly failed — to explain steep cost increases of her company's life-saving EpiPens.
Outraged Republican and Democratic lawmakers on Wednesday grilled Bresch about the emergency allergy shot's sky-high price and the profits for a company with sales in excess of $11 billion. The list price of EpiPens has grown to $608 for a two-pack, an increase of more than 500 percent since 2007.
In almost four hours of questioning, the soft-spoken CEO at times seemed unsure, or declined to answer directly, when asked questions about the compan...
Source: JEMS Patient Care - September 23, 2016 Category: Emergency Medicine Tags: News Patient Care Source Type: news
Gene-based Zika vaccine is safe and immunogenic in healthy adults
(NIH/National Institute of Allergy and Infectious Diseases) Results from two Phase 1 clinical trials show an experimental Zika vaccine developed by government scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is safe and induces an immune response in healthy adults. The findings will be published on Dec. 4 in The Lancet. NIAID is currently leading an international effort to evaluate the investigational vaccine in a Phase 2/2b safety and efficacy trial.
Source: EurekAlert! - Infectious and Emerging Diseases - December 4, 2017 Category: Infectious Diseases Source Type: news
UCLA researchers use search engines, social media to predict syphilis trends
UCLA-led research finds that internet search terms and tweets related to sexual risk behaviors can predict when and where syphilis trends will occur.Two studies from the UCLA-based University of California Institute for Prediction Technology, in collaboration with the Centers for Disease Control and Prevention, or CDC, found an association between certain risk-related terms that Google and Twitter users researched or tweeted about and subsequent syphilis trends that were reported to the CDC. The researchers were able to pinpoint these cases at state or county levels, depending on the platform used.“Many of the most signi...
Source: UCLA Newsroom: Health Sciences - April 11, 2018 Category: Universities & Medical Training Source Type: news
A Temporary Fix for the EpiPen Crisis?
The ongoing saga of the EpiPen shortage crisis took a new turn today as FDA made a move to extend the expiration dates of certain lots of the allergy drug-device combo by four months.
The recent EpiPen shortage has caused FDA to extend the expiration dates of certain lots of the allergy drug-device combo by four months. The products effected are the EpiPen 0.3 mg Auto-Injectors and its authorized generic version. This measure by FDA was made after a review of stability data.
Mylan's product treats life-threatening allergic reactions by automatically injecting a dose of epinephrine, also known as adrenaline. The...
Source: MDDI - August 21, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news
Moderna ’s COVID-19 Vaccine Enters Final Testing Phase, As Researchers Dose the Study’s First Volunteer
Moderna Therapeutics and the National Institute of Allergy and Infectious Diseases (NIAID) announced today that researchers had injected the first volunteer in the first U.S. coronavirus vaccine to reach the final, phase 3 stage of testing.
That person received the shot at 6:45 am eastern time in Savannah, Geo., Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) told reporters during a briefing. Because the trial will randomly assign participants to receive either the vaccine or a placebo, and neither the researchers nor the volunteers will kn...
Source: TIME: Health - July 27, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news
Johnson & Johnson ’ s Coronavirus Vaccine Enters Phase 3 Trial With Beth Israel
cbsoptanon.onScriptsReady(function(cmp){cmp.ot.targetingAllowed(function(a){if(a) AnvatoPlayer("p1").init({"mcp":"cbs","width":"100%","height":"100%","video":"4730668","autoplay":false,"titleVisible":false,"accessKey":"EZqvRyKE7qmqDflDPXIw6U7kKZEA0Vx7","accessControl":{"preview":false},"pInstance":"p1","plugins":{"heartbeat":{"account":"cbslocal-global-unified","publisherId":"cbslocal","jobId":"sc_va","marketingCloudId":"823BA0335567497F7F000101@AdobeOrg","trackingServer":"cbsdigitalmedia.hb.omtrdc.net","customTrackingServer":"cbsdigitalmedia.d1.sc.omtrdc.net","chapterTracking":false,"version":"1.5"},"comscore":{"clientId"...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - September 23, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Covid-19 Boston, MA Health Healthcare Status Beth Israel Deacones Medical Center Coronavirus Johnson & Johnson Source Type: news
Biden ’s First Three Steps to Getting COVID-19 Vaccines to Every American
Less than a week after taking office, President Joe Biden announced three major steps to improve the country’s vaccination plans, and his Administration’s COVID-19 response team held its first press briefing.
On Jan. 26, the President outlined the first three steps his team will take as part of a National Action Strategy for responding to the pandemic. First, the Administration will increase minimum weekly shipments of vaccines to states to 10 million doses, from the current 8.6 million. Next, Biden guaranteed these shipment numbers for the next three weeks, which allows states to plan out for the next month ho...
Source: TIME: Health - January 27, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news
The Pandemic Remade Every Corner of Society. Now It ’s the Climate’s Turn
On her third day as the Secretary of Housing and Urban Development, Marcia Fudge phoned the White House. She had taken over an agency with a role to play addressing a range of crises as the lack of affordable housing in U.S. cities has left hundreds of thousands homeless and millions more in financial straits. She connected with Joe Biden’s climate team. Fudge and Gina McCarthy, Biden’s national climate adviser, talked about addressing climate change and the affordable-housing shortage at the same time. Three weeks later, the Administration announced plans to provide for more than 1 million resilient and e...
Source: TIME: Science - April 15, 2021 Category: Science Authors: Justin Worland Tags: Uncategorized climate change Cover Story feature Magazine TIME 2030 Source Type: news
AI Cough-Monitoring Can Change the Way We Diagnose Disease
How many times do you cough a day? Do you cough more when you’re indoors or outside? Or more often after you eat? Or at night?
Chances are, your cough memory might not be that accurate. But all of that information about your coughing patterns could be an untapped resource to better understand your health. Coughs may be benign ways to clear a little extra phlegm, or they could be early signs of more serious conditions such as asthma, GERD (gastroesophageal reflux disease), or even lung cancer.
“In the era of precision health, it’s ironic that such a problematic symptom is simply unmeasured,” says Pet...
Source: TIME: Health - April 3, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Technology Source Type: news
